<DOC>
	<DOCNO>NCT02979093</DOCNO>
	<brief_summary>A prior study principal investigator project identify dopamine- oxytocin-related brain pathway show diminished response addict mother view face vs. unknown infant , compare non-addicted mother . These area include hypothalamus , striatum ventromedial prefrontal cortex . Oxytocin , neuropeptide decrease blood level see addict mother , integrally involved maternal brain behavioral response . When administer intranasally , pilot data show enhanced activation striatum , prefrontal cortex ( PFC ) amygdala . The purpose study continue expand upon previous investigation maternal addiction , conduct randomize , double-blinded , placebo control , crossover study intranasal oxytocin maternal brain response . 150 mother University Iowa Yale Child Study Center enrol ( 75 history drug addiction 75 match control mother ) , along 2 12-month-old infant , participate four study visit two-month period .</brief_summary>
	<brief_title>Oxytocin Brain Responses Maternal Addiction</brief_title>
	<detailed_description>Maternal drug addiction constitute major public health problem woman affect child , long lasting consequence child 's social , emotional cognitive development . Current treatment strategy tend focus mother current addiction , rather relationship child , developmental process may perpetuate addiction problem , unresolved childhood attachment trauma , neglect , chronic stress . Unlike mother find engaging infant uniquely reward experience , mother addiction may less able respond appropriately infant 's cue , find less intrinsically reward salient , stress provoking . Aim 1 : To examine , addict mother compare non-addicted control mother , effect intranasal oxytocin ( OT ) functional MRI brain response reward-related cue : vs. unknown happy infant face . Aim 2 : To examine , addict mother compare non-addicted control mother , effect intranasal OT brain response stress-related cue : vs. unknown sad infant face . Aim 3 : To examine effect intranasal OT functional brain connectivity , include striatum , PFC amygdala . Specifically , explore whether , receive intranasal OT compare placebo , addict mother show increased functional connectivity amygdala ( ) ventromedial PFC own-happy infant face , ( ii ) dorsolateral PFC striatum own-sad face . Aim 4 : To explore individual difference adult attachment mother-infant synchrony , sensation-seeking/risk-taking stress/trauma exposure associate OT brain response infant face .</detailed_description>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Inclusion Criteria addiction sample : Drugaddicted subject English speak adult woman : 1. evaluate treatment addiction currently enrol treatment program ; 2. infant &lt; 12 month ; 3. meet criterion substance abuse dependence past year , assess MINI International Neuropsychiatric Interview ( MINI ) ; 4. substance abuse history , include use recent pregnancy ; 5. recommend intake drugtreatment service substance abuse ; 6. 18 year old ; 7. speak English enrol Englishspeaking school since age 8 . Inclusion Criteria nonaddicted mother ( control ) : Control subject Englishspeaking adult woman : 1. infant &lt; 12 month age ; 2. meet criterion past present drug abuse dependence ; 3. 18 year old ; 4. speak English enrol Englishspeaking school since age 8 . Exclusion Criteria addiction sample : Potential drugaddicted subject ineligible : 1. severe psychiatric substancerelated symptom require inpatient psychiatric hospitalization detoxification suicidality , homicidality , grave disability , physiological alcohol drug withdrawal within last 30 day ; 2. past present diagnosis schizophrenia psychotic disorder ; 3. metal implant contraindication MRI scanning ; 4. pending legal case ( e.g. , outstanding arrest warrant parental right hearing ) prohibit complete study ; 5. current pregnancy plan become pregnant course study ; 6. infant clinical evidence utero drug effect , opiate withdrawal symptom neonatal period , facial dysmorphism intrauterine growth restriction ( IUGR ) microcephaly ; 7. infant birth weight less 3 lb . 5 oz . ; 8. infant significant vision , hear motor problem ( cerebral palsy ) correct ; 9. outofhome placement infant past month 50 % child 's life ; 10. deliver one baby recent pregnancy ( twin , triplet , etc. ) . Exclusion criterion nonaddicted mother : Potential control subject ineligible : 1. positive drug toxicology screen time study ; 2. drug abuse dependence base MINI past year lifetime ; 3. use tobacco product past 2 year ; 4. current hazardous alcohol use ascertain AUDIT score &gt; 8 ; 5. present past history ambulatory detoxification ; 6. severe psychiatric symptom require inpatient psychiatric hospitalization suicidality , homicidality , grave disability , physiological alcohol drug withdrawal within past 30 day ; 7. past present diagnosis schizophrenia psychotic disorder ; 8. metal implant contraindication MRI scanning ; 9. current pregnancy plan become pregnant course study ; 10. infant birth weight less 3 lb . 5 oz . ; 11. infant significant vision , hear motor problem correct ( cerebral palsy ) ; 12. outofhome placement infant past month 50 % child 's life ; 13. deliver one baby recent pregnancy ( twin , triplet , etc . ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>maternal drug addiction</keyword>
	<keyword>mother-infant attachment</keyword>
	<keyword>intranasal oxytocin</keyword>
	<keyword>unresolved trauma</keyword>
	<keyword>maternal brain response</keyword>
	<keyword>mother-infant synchrony</keyword>
</DOC>